Delivery Order SPE2DB20D1109-SPE2DB25FM93A

Award Date 10/10/24
Potential Completion Date 10/11/24
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,431.75 firm fixed-price delivery order is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product. The contract has an ultimate completion date of December 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,091.83, is for the delivery of PROGRAF 5 MG/ML AMPULEML, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $5,076.81 firm fixed price delivery order is for the supply of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a period of performance through March 21, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROGRAF 1 MG CAPSULE 100S. The contract has a firm fixed price of $5,078.88 and an ultimate completion date of September 12, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, through its Corporate Office Division, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by...
This federal contract award, with ID SPE2DB20D1100|SPE2DB24FA1G6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of PROGRAF 1 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $36,349.69. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of February 8, 2024. It was awarded on February 7, 2024, and there was no set-aside...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, a Delivery Order valued at $1,107.95, is for the supply of PROGRAF 0.5 MG CAPSULE 100S, a prescription medication. The contract has a Firm Fixed Price pricing type and a completion date of May 19, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,591.79 firm-fixed-price delivery order is for the provision of Prograf 1 mg capsules. The contract has an ultimate completion date of October 24, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $8,646.10, is for the delivery of PROGRAF 5 mg capsules to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of AmerisourceBergen Corporation, is for the supply of PROGRAF 1 MG CAPSULE 100S pharmaceutical product. The $2,310.51 fixed-price delivery order was awarded on May 1, 2024 by the Medical Supply Chain division of the Defense agency, with a performance completion date of May 2, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop...
This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $12,381.60 firm fixed price delivery order is for the supply of 4,564,660 units of the pharmaceutical product PROGRAF 1 MG CAPSULE 100S. The contract has a period of performance through May 21, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FM93A
    Delivery Order

This federal contract award is a delivery order worth $3,773.23 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of PROGRAF 1 MG CAPSULE 100S, a medical product, with a completion date of October 11, 2024.

The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any major subcontractors. The DLA, as a defense agency, is responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces, and this contract award supports the agency's mission of supplying essential medical products to military healthcare facilities and programs.

Generated 2/27/25, 11:18 AM